We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
-12.85%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$1.17B
AUM Growth
-$301M
Cap. Flow
-$33.3M
Cap. Flow %
-2.85%
Top 10 Hldgs %
56.5%
Holding
52
New
9
Increased
12
Reduced
9
Closed
8

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$83.6M
2
MJN
Mead Johnson Nutrition Company
MJN
+$49.4M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$27.8M
4
THC icon
Tenet Healthcare
THC
+$25.8M
5
HMSY
HMS Holdings Corp.
HMSY
+$24.3M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$48.6M
2
MASI
Masimo
MASI
+$36.8M
3
XRAY icon
Dentsply Sirona
XRAY
+$25.8M
4
PRGO icon
Perrigo
PRGO
+$22.7M
5
ESRX
Express Scripts Holding Company
ESRX
+$13.1M

Sector Composition

Rank Sector Weight
1 Healthcare 71.52%
2 Consumer Staples 3.62%
3 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEVA icon
1
Teva Pharmaceuticals
TEVA
$40.4B
$113M 9.67%
2,000,000
+250,000
+14% +$16.2M
MDCO
2
DELISTED
Medicines Co
MDCO
$94.9M 8.13%
2,500,000
– –
AZN icon
3
AstraZeneca
AZN
$269B
$79.5M 6.81%
1,250,000
– –
CYBX
4
DELISTED
CYBERONICS INC
CYBX
$60.8M 5.21%
1,000,000
– –
VTRS icon
5
Viatris
VTRS
$20.8B
$60.4M 5.17%
+1,500,000
New +$83.6M
NUVA
6
DELISTED
NuVasive, Inc.
NUVA
$53M 4.54%
1,100,000
– –
GHDX
7
DELISTED
Genomic Health, Inc.
GHDX
$51.8M 4.44%
2,450,000
+350,000
+17% +$9.02M
OFIX icon
8
Orthofix Medical
OFIX
$492M
$50.6M 4.34%
1,500,000
– –
ESRX
9
DELISTED
Express Scripts Holding Company
ESRX
$48.6M 4.16%
600,000
-150,000
-20% -$13.1M
SEM
10
DELISTED
Select Medical
SEM
$46.9M 4.02%
8,073,600
+1,577,600
+24% +$11.7M
LH icon
11
Labcorp
LH
$25.2B
$43.4M 3.72%
465,600
– –
MJN
12
DELISTED
Mead Johnson Nutrition Company
MJN
$42.2M 3.62%
+600,000
New +$49.4M
UAM
13
DELISTED
Universal American Corp
UAM
$40.2M 3.44%
5,875,000
+640,102
+12% +$5.19M
MASI
14
DELISTED
Masimo
MASI
$38.6M 3.3%
1,000,000
-900,000
-47% -$36.8M
ARIA
15
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$32.3M 2.77%
5,533,118
-216,882
-4% -$1.67M
NKTR icon
16
Nektar Therapeutics
NKTR
$2.39B
$24.7M 2.11%
150,000
+50,000
+50% +$8.84M
SQNM
17
DELISTED
SEQUENOM INC NEW
SQNM
$20.6M 1.76%
11,750,000
+2,750,000
+31% +$6.73M
CCRN
18
DELISTED
Cross Country Healthcare
CCRN
$20.3M 1.74%
1,493,765
– –
ALNY icon
19
Alnylam Pharmaceuticals
ALNY
$38.3B
$20.1M 1.72%
+250,000
New +$27.8M
HMSY
20
DELISTED
HMS Holdings Corp.
HMSY
$19.1M 1.64%
+2,179,900
New +$24.3M
ARNA
21
DELISTED
Arena Pharmaceuticals Inc
ARNA
$18.6M 1.6%
975,000
+225,000
+30% +$7.64M
THC icon
22
Tenet Healthcare
THC
$22.2B
$18.5M 1.58%
+500,000
New +$25.8M
KND
23
DELISTED
Kindred Healthcare
KND
$17.3M 1.48%
1,100,000
– –
DGX icon
24
Quest Diagnostics
DGX
$26B
$13.4M 1.15%
218,500
-31,500
-13% -$2.2M
AMRN
25
Amarin Corp
AMRN
$297M
$12.5M 1.07%
325,000
-175,000
-35% -$7.94M
1
2

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, Camber Capital Management held 52 positions worth $1.17B, down 21% from $1.47B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Camber Capital Management's Q3 2015 filing shows 9 new, 12 increased, 9 reduced and 8 closed positions. Its largest new stake was Viatris: 1,500,000 shares worth $60.4M. The largest sale was Cigna, an estimated $48.6M.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, up from 66% a quarter earlier, followed by Consumer Staples and Industrials.

  • Camber Capital Management's largest Q3 2015 buy was Viatris: 1,500,000 shares worth $60.4M.
  • Camber Capital Management added most to Teva Pharmaceuticals in Q3 2015, an estimated $16.2M increase.
  • Camber Capital Management's biggest Q3 2015 reduction was Masimo, cutting an estimated $36.8M.
  • Camber Capital Management fully exited Cigna in Q3 2015, selling an estimated $48.6M.
  • Camber Capital Management's ten largest holdings make up 57% of its $1.17B portfolio in Q3 2015.
  • Camber Capital Management opened 9 new positions and closed 8 in Q3 2015.
  • Camber Capital Management's portfolio value fell 21% quarter-over-quarter to $1.17B.

Based on Camber Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.